Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

Compare-Acute Sub-Study: Natural History of Non-Culprit Lesions in MI

The aim of this study was to determine the prognostic value of fractional flow reserve (FFR) of non-culprit lesions in STEMI patients. 

Sub-estudio del Compare-Acute: Historia natural de las lesiones no culpables del infarto

We analyzed data of all Compare-Acute patients (Comparison Between FFR Guided Revascularization Versus Conventional Strategy in Acute STEMI Patients With MVD) after PCI, from lesions assessed with FFR and treated medically.  The treating cardiologists were blind to FFR values. 

Primary end point was a The primary endpoint was the composite of cardiovascular mortality, target vessel-related (non-IRA with FFR measurement at primary percutaneous coronary intervention) nonfatal MI, and target vessel revascularization: major adverse cardiac events at 24 months. 

It included 751 patients (963 vessels). Non-culprit lesions that were not revascularized showed significantly lower FFR (0.78 vs. 0.84; p<0.001). 

This difference was significative in all vessels.


Read also: Bleeding and Cardiogenic Shock: An “Unholy Alliance”?


Mean FFR of original non- culprit lesions that later presented as MI also resulted lower (0.79 vs. 0.84; p=0.016).

All data point to a significantly higher events rate (p<0.001) in the lowest tertile of FFR (<0.80) compared against the two higher tertiles (0.80 to 0.87 and >0.88).

This phenomenon has been seen in previous studies. We should get rid of this idea of FFR provides a binary cutoff value around 0.8 and rather understand these results as a continuum of variables.  


Read also: COMPARE-ACUTE: FFR-Guided Non-Culprit Vessel Revascularization in Primary Angioplasty.


In any given lesion, the closer to 0.8, the higher the chances of these lesions evolving with events. This increase in bad odds is not linear, but rather shoots up disproportionally the closer we get to 0.8.

Conclusion

In patients with ST elevation MI and multivessel disease undergoing medical treatment in non-culprit lesions after successful primary PCI, there is a non-linear and inverse correlation between FFR values in non-culprit lesions and events. 

It is important to highlight there is worse prognosis around the 0.8 cutoff value.

Original Title: The Natural History of Nonculprit Lesions in STEMI. An FFR Substudy of the Compare-Acute Trial.

Reference: Zsolt Piróth et al. J Am Coll Cardiol Intv 2020;13:954–61.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...

EuroPCR 2026 | TAVI and Coronary Artery Disease: FFR-Guided PCI Showed Better Outcomes Than an Angiography-Guided Strategy

In patients undergoing TAVI, the concomitant presence of coronary artery disease continues to generate debate: whether coronary lesions should be treated before, during, or...

EuroPCR 2026 | Evolocumab Reduces Cardiovascular Events in Patients With Prior PCI Without Previous Myocardial Infarction: VESALIUS-CV Results

This presentation, delivered by Dr. Brian A. Bergmark and colleagues at EuroPCR 2026, detailed the results of the VESALIUS-CV trial, focusing specifically on the...

EuroPCR 2026 | Is It Safe to Stop Aspirin After One Month in MI Patients Undergoing PCI? TARGET-FIRST Analysis

This is a summary of the post-hoc analysis of the TARGET-FIRST study, presented by Dr. Giuseppe Tarantini at EuroPCR 2026, evaluating early aspirin discontinuation...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

EuroPCR 2026 | TAVI in Women: Do Supra-Annular Valves Offer a True Hemodynamic Advantage?

Women represent a particularly challenging population for TAVI, as they often have smaller aortic annuli, greater frailty, and an increased risk of prosthesis-patient mismatch....

EuroPCR 2026 | TAVI or Surgery in Younger Patients? Quality of Life and 3-Year Outcomes from NOTION-2

The expansion of TAVI into younger and lower surgical-risk populations has sparked a new debate: beyond mortality and stroke, which strategy provides better functional...

EuroPCR 2026 | MELA Registry: Myval Showed Lower Aortic Regurgitation Rates in Patients With Large Aortic Annuli

This presentation, delivered by Dr. Salvatore Giordano at EuroPCR 2026, detailed the results of the MELA Registry, a multicenter study comparing the performance of...